North America AREDS 2 Supplements Market To Reach USD 423.1 Million By 2030


 

North America AREDS 2 Supplements Market Growth & Trends

The North America AREDS 2 supplements market size is expected to reach USD 423.1 million by 2030, registering a CAGR of 6.1% from 2024 to 2030, according to a new report by Grand View Research, Inc. The North America AREDS 2 supplements market is experiencing significant growth, driven by a combination of health trends, demographic shifts, and technological advancements. At the forefront of this growth is the increasing prevalence of chronic eye diseases, particularly Age-related Macular Degeneration (AMD). The AREDS 2 formula, which includes specific dosages of zinc, lutein, zeaxanthin, and various vitamins, has shown promising results in reducing the risk of disease progression and preserving functional vision, making it a go-to choice for those at risk or already affected by AMD.

Awareness about eye health and the benefits of supplements like AREDS 2 has grown substantially in recent years. This increased awareness, coupled with the widespread availability of these supplements over-the-counter and through various sales channels, including online platforms, has significantly boosted market growth. The COVID-19 pandemic has further accelerated this trend, with a notable increase in internet sales of eye health supplements. This shift in consumer behavior has made these products more accessible to a broader audience, contributing to the market's expansion.

Product innovation and new launches are playing a crucial role in driving the market forward. Companies in the sector are continuously developing new formulations to meet evolving consumer needs. For instance, in May 2024, EyePromise, a leading nutraceutical company specializing in eye health, unveiled the latest enhancements to its extensive nutritional program tailored for eyecare practices. Focused on innovation and enhancement, EyePromise has enhanced its AREDS 2-based products. These scientifically backed formulas will now be branded as Macular Health and Macular Health Complete.

Request a free sample copy or view report summary: https://www.grandviewresearch.com/industry-analysis/north-america-areds-2-supplements-market-report

North America AREDS 2 Supplements Market Report Highlights

  • North America AREDS 2 soft gels market accounted for a share of over 49% of the North Americas revenues in 2023. This innovative two-in-one soft gel addresses the needs of the aging population who are managing both age-related macular degeneration (AMD) and heart disease, offering a convenient solution that simplifies their supplement regimen. Leading companies are enhancing their product offerings with soft gels, which are favored for their ease of swallowing, precise dosage, and better absorption
  • The sales of North America AREDS 2 supplements through online distribution channels are projected to grow at a CAGR of 6.9% from 2024 to 2030. AREDS 2 supplements offered by most companies are available through Amazon, providing an online shopping option for those who prefer digital convenience. Companies prefer a multi-channel approach to enhance product availability and meet the diverse purchasing preferences of North American consumers. The COVID-19 pandemic further accelerated the shift towards online shopping as consumers prioritize health and safety
  • The AREDS 2 supplements market in the U.S. is projected to grow at a CAGR of 6.3% from 2024 to 2030. The market for AREDS 2 supplements in the U.S. is primarily driven by the growing awareness of age-related macular degeneration (AMD) and the desire for preventative measures among the aging population. AMD is a leading cause of vision loss among older adults, making it a significant public health concern

North America AREDS 2 Supplements Market Segmentation

Grand View Research has segmented the North America AREDS 2 supplements market on the basis of product, distribution channel, and country.

North America AREDS 2 Supplements Product Outlook (Revenue, USD Million, 2018 - 2030)

  • Capsules
  • Tablets
  • Soft gels
  • Others

North America AREDS 2 Supplements Distribution Channel Outlook (Revenue, USD Million, 2018 - 2030)

  • Pharmacies
  • Online
  • Others

North America AREDS 2 Supplements Country Outlook (Revenue, USD Million, 2018 - 2030)

  • North America
    • U.S.
    • Canada
    • Mexico

List of Key Players in the North America AREDS 2 Supplements Market

  • Bausch + Lomb
  • Alcon Inc.
  • Nature Made (Pharmavite LLC)
  • EyePromise (ZeaVision, LLC)
  • MacuHealth
  • Viteyes (Vitamin Health, Inc.)
  • Codeage LLC
  • NATURELO Premium Supplements, LLC
  • NutraChamps Inc.
  • VISTA

Browse Full Report: https://www.grandviewresearch.com/industry-analysis/north-america-areds-2-supplements-market-report

Comments

Post a Comment

Popular posts from this blog

Virtual Clinical Trials Market Size Reaches USD 12.9 Billion By 2030

Image
  The global  virtual clinical trials market  size is expected to reach USD 12.9 billion by 2030, according to a new report by Grand View Research, Inc. The market is expected to expand at a CAGR of 5.7% from 2022 to 2030. The COVID-19 pandemic has significantly impacted the market. The growing need for patient diversity clubbed with enhanced data collection in clinical trials is boosting the market growth. There has been a rise in the R&D of new drugs and vaccines that has increased the volume and complexity of clinical trials. Virtual clinical trials eliminate challenges posed by traditional clinical trials for example delays in patient recruitment and time-consuming procedures. Also, studies have revealed that around 75.0% of people favored a mobile trial over traditional ones and 80.0% of patients are more likely to participate in a clinical trial that uses mobile technology. The market is recovering at a significant pace after the pandemic as it offers various benefits to pati
Read more

Industrial Refrigeration Systems Market Size, Share & Trends Report, 2030

Image
  Industrial Refrigeration Systems Market Growth & Trends The global  industrial refrigeration systems market  size is anticipated to reach USD 27.66 billion by 2030, registering a CAGR of 4.4% from 2023 to 2030, according to a new report published by Grand View Research, Inc. The demand for industrial refrigeration is increasing due to the fast-moving consumer goods and retail food which needs efficient storage for perishable edible items. Governments are taking initiatives to support and strengthen the cold chain infrastructure and shifting towards eco-friendly refrigeration systems. Global warming and climate change have alarmed nations to take the necessary step to curb the crisis. As a result, industrial refrigeration system manufacturing companies have expressed concerns regarding the potential of global warming and ozone depletion of their refrigerants. As a result, companies are focusing on technologies to offer improved cost-effectiveness, lesser toxic refrigerants, lower
Read more

U.S. Virtual Visits Market Size To Reach USD 105.5Bn By 2030

Image
  U.S. Virtual Visits Market Growth & Trends The  U.S. virtual visits market  size is expected to reach USD 105.5 billion by 2030, expanding at a CAGR of 29.9% from 2023 to 2030, according to a new report by Grand View Research, Inc. Increasing demand for telehealth and teleconsultation and introduction of new and advanced technologies has positively impacted the growth of the market in the U.S. Increasing penetration of smartphones and assisted technologies has also been a key factor for the fast growth of the market. In the service segment, cold and flu management had the largest market share in 2022. The major factor behind the growth of the market is the growing demand for teleconsultations for patients for treatment of common conditions like cold and flu to reduce the chances of contracting additional illnesses due to hospital visits. The availability of specialists through telehealth and teleconsultations, even in remote areas has brought about a revolution in the virtual
Read more